Literature DB >> 12847756

Allopurinol hypersensitivity syndrome.

Bryan E Anderson1, David R Adams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12847756

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN： 1545-9616            Impact factor:   2.114


× No keyword cloud information.
  5 in total

1.  [Allopurinol-induced hypersensitivity syndrome resulting in death].

Authors:  Sören Laurisch; Maren Jaedtke; Reyhan Demir; Sajoscha A Sorrentino; Jan T Kielstein; Hans-Oliver Rennekampff; Peter M Vogt; Gerd P Meyer; Martin Fuchs; Gunnar Klein; Hartmut Drexler; Bernhard Schieffer; L Christian Napp
Journal:  Med Klin (Munich)       Date:  2010-04

2.  Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia.

Authors:  Alfonso Gutiérrez-Macías; Eva Lizarralde-Palacios; Pedro Martínez-Odriozola; Felipe Miguel-De la Villa
Journal:  BMJ       Date:  2005-09-17

Review 3.  Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase.

Authors:  John S Bomalaski; Mike A Clark
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

Review 4.  The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD.

Authors:  Yuka Sato; Daniel I Feig; Austin G Stack; Duk-Hee Kang; Miguel A Lanaspa; A Ahsan Ejaz; L Gabriela Sánchez-Lozada; Masanari Kuwabara; Claudio Borghi; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2019-07-11       Impact factor: 28.314

Review 5.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.